Highlights Eurocine Vaccines AB

Equities

EUCI

SE0015382155

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
0.0398 ^SEK	-5.24%		-36.83%	-13.48%

Feb. 28	Eurocine Vaccines AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI
Feb. 15	Certain Shares of Eurocine Vaccines AB are subject to a Lock-Up Agreement Ending on 15-FEB-2024.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Eurocine Vaccines AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 28	CI
Eurocine Vaccines AB Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 28	CI
Eurocine Vaccines AB Reports Earnings Results for the Fourth Quarter Ended June 30, 2023	23-08-30	CI
Eurocine Vaccines AB Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-30	CI
Eurocine Vaccines AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-24	CI
Eurocine Vaccines Wins SEK300,000 Grant from Merck KGaA	23-05-04	MT
Eurocine Vaccines AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-02-28	CI
Eurocine Vaccines to Develop Chlamydia Vaccine Candidate Using mRNA	23-01-18	MT
Eurocine Vaccines AB Decides to Develop mRNA-Based Vaccine Candidate Against Chlamydia	23-01-17	CI
Eurocine Vaccines AB Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-28	CI
Eurocine Vaccines Receives Patent Coverage In South Korea For Vaccine Candidate	22-08-30	MT
Eurocine Vaccines AB Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-25	CI
Eurocine Vaccines AB Reports Earnings Results for the Fourth Quarter Ended June 30, 2022	22-08-25	CI
Eurocine Vaccines Down 10% On Collaboration Deal With Redbiotec For Herpes Vaccine	22-06-15	MT
Eurocine Vaccines AB Enters into Research and Collaboration Agreement with Redbiotec AG	22-06-14	CI
Eurocine Vaccines AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	22-05-20	CI
Eurocine Vaccines AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	22-02-16	CI
Eurocine Vaccines Resolves on Scientific Advice with Swedish Medical Products Agency ahead of Clinical Trial Application	21-12-21	CI
Eurocine Vaccines AB Reports Earnings Results for the First Quarter Ended September 30, 2021	21-11-17	CI
Eurocine Vaccines Announces Positive Results with Endocine and A Vaccine Candidate Against Covid-19	21-09-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Eurocine Vaccines AB

Equities

EUCI

SE0015382155

Highlights

Filters